01/07 Grifols S A : reorganizes its operating model to accelerate execution of its strategic roadmap PU
29/06 Grifols S A : doses first participant in Phase 3 study evaluating novel subcutaneous therapy for alpha1-antitrypsin deficiency PU
26/06 Delisting (ISIN NUMBER: XS2077646391 (Reg. S) / XS2077647365 (144A)) AQ
26/06 Partial Redemption (ISIN NUMBER: XS2805351843 (Reg. S) / XS2805352064 (144A)) AQ
22/06 Grifols, S.A. Announces Board and Committee Changes, Effective June 19, 2026 CI
22/06 Changes in the Composition of the Board of Directors and Board Committees AQ
19/06 Bestinver Securities Lowers Grifols PT, Keeps at Buy MT
18/06 Grifols S A : Shareholders approve key resolutions at the 2026 Annual General Shareholders’ Meeting PU
18/06 Grifols Communications - Resolutions adopted by the Board of Directors AQ
15/06 Grifols Launches Fesilty in the U.S CI
15/06 Grifols Launches Fesilty Blood Clotting Concentrate in US MT
15/06 Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S. AQ
12/06 Grifols S A : Egypt continues its growth plan through 2029 with an additional investment of €180 million PU
03/06 Grifols S A : breaks ground on new manufacturing site in Spain PU
26/05 Grifols S A : doubles the number of positions in its vocational training program over the past year in Spain PU
26/05 Grifols' Insatiable Appetite Zonebourse
25/05 CaixaBank Trims Grifols' PT, Maintains Buy Rating MT
15/05 PRESS DIGEST-Canada - May 18 RE
15/05 Ordinary General Shareholders' Meeting AQ
08/05 Grifols: FCFs didn't impress; rebuilding trust isn't going to be easy Alphavalue
08/05 Grifols Disappoints, Shares Lose Ground Zonebourse
08/05 Moody's Changes Grifols Outlook to Positive MT
08/05 Grifols Q1 Adjusted Profit Rises, Revenue Falls MT
08/05 Grifols S A : Conference call transcript (a065ff21 61b9 2f2c 67fc 1284cdbb08dct1778229612320) PU
08/05 Grifols, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
No results match your criteria